These findings were consistent with results from UALCAN, which confirmed that the expression of all LOX family members was statistically significantly higher in tumor tissue (Figure 1B), and from TIMER, which showed higher expression of LOX (P=1.5E-11), LOXL1 (P=2.39E-04), LOXL2 (P=4.02E-25), LOXL3 (P=1.53E-04), and LOXL4 (P=7.15-05). Here, LOXL1 is linked to neoplasm.